Drug target · GRIN2D

GluN2D

Glutamate ionotropic receptor NMDA type subunit 2D

1 compound in the CNS pipeline acts on GluN2D.

Compounds targeting GluN2D

CompoundActionAffinityLead programDeveloper
Esmethadone (REL-1017)primarySmall moleculeAntagonistIC50 13.5 uMDiscontinuedMajor depressive disorderRelmada Therapeutics, Inc.